Advertisement

Picture Demy-Colton BioFuture 2021 NYC C Virtual Option 650x80px
Organisation › Details

Droia Ventures (Group)

Droia is a specialist biotech investor with an exclusive focus on therapeutics for oncology and genetic disease. Droia manages over EUR 450 million (USD 550 million) which it invests globally in newly founded or early-stage platform companies that apply novel science and innovative technologies to bring first-in-class drug candidates to patients. With our team of seasoned scientists, entrepreneurs and investment professionals we build great companies to save patient lives. *

 

Period Start 2020-04-30 existent
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Persons Person Dochez, Luc (Vico Therapeutics 202007 CEO + Co-Founder + Droia Genetic Disease Fund Managing Partner before Prosensa)
  Person 2 Naesens, Janwillem (Droia Oncology Ventures 201701 Partner)
     
Region Region Belgium_oo
  Country Belgium
  Street 11 Brusselsesteenweg
  City 1860 Meise
  Tel +32-2-880-6730
    Address record changed: 2021-05-30
     
Basic data Employees n. a.
  Currency EUR
  Annual sales 450,000,000 (funds, managed (2021) 2021-05-11)
     
    * Document for �About Section�: Droia Ventures. (5/11/21). "Press Release: Droia Ventures Raises a New Fund of EUR 220 Million to Target Genetic Diseases and Expands Leadership Team with George Golumbeski". Brussels.
     
   
Record changed: 2021-05-30

Advertisement

Picture [iito] Plain Stupid Simple 650x80px

More documents for Droia Ventures (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Network in German Capital Region 650x80px




» top